A genetic condition known as sickle cell disease (SCD) results in excruciating pain episodes because sickle-shaped red blood cells restrict blood flow. Systemic opioid administration, which is linked to delayed pain relief, dependency risks, and hospital reliance, is the foundation of traditional pain treatment procedures (Ballas, 2020; Vuckovic et al., 2020). A viable solution to these issues is the creation of a wearable medication delivery device specifically designed for children with sickle cell disease. Transdermal microneedle patches and infusion pumps are examples of wearable drug delivery devices that allow for focused and regulated medication administration, decreasing the need for hospital-based interventions and increasing patient compliance (Prausnitz
[Solved]: A genetic condition known as sickle cell disease…
Need help with your Pain Management & Analgesics case study or NCLEX preparation? Connect with a verified Nursing expert now.